Cancer Research UK Chooses Medidata Clinical Cloud

March 27, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK.

Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK. By providing a standardized, central system for data entry, the Medidata platform is intended to improve data quality, allow clinicians to easily monitor patients’ safety and enable more insightful decision making across all CDD trials.

 

Read the full release here.

Related Content:

News